Literature DB >> 17171573

Prevalence of use, abuse and dependence on legal and illegal psychotropic substances in an adolescent inpatient psychiatric population.

Oliver Niethammer1, Reiner Frank.   

Abstract

OBJECTIVE: To examine the prevalence of use, abuse, and dependence on legal and illegal psychotropic substances in an adolescent in-patient psychiatric population in relation to age and gender.
METHODS: Participants were all consecutive admissions (patients aged from 14 to 17) to the adolescent psychiatric in-patient unit. Of the 86 patients who met all the criteria for taking part in the study 70 were interviewed, giving a response rate of 81%. Prevalence of use and of substance use disorders were assessed through structured diagnostic interviews (M-CIDI), conducted from March 2000 through July 2000.
RESULTS: We found high prevalence of use and of the diagnosis of legal and illegal psychotropic substances. Around 76% reported a regular use of tobacco, 44% regular alcohol use, and 40% regular use of illegal substances. Diagnosis (abuse or dependence) was found in 50% of cases for nicotine, 29% for alcohol, and 26% for illegal substances.
CONCLUSIONS: The adolescent in-patient psychiatric population is at high risk of use, abuse, and dependence on legal and illegal psychotropic substances. It is important to diagnose these disorders (anamnesis, screening tools) and to install preventive and therapeutic programs in clinical therapeutic settings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17171573     DOI: 10.1007/s00787-006-0597-5

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  16 in total

1.  The EDSP: setting the stage!

Authors:  C B Nelson; H U Wittchen
Journal:  Eur Addict Res       Date:  1998-03       Impact factor: 3.015

Review 2.  Substance use, abuse and dependence in Germany. A review of selected epidemiological data.

Authors:  A Perkonigg; R Lieb; H U Wittchen
Journal:  Eur Addict Res       Date:  1998-03       Impact factor: 3.015

3.  Psychiatric comorbidity among adolescents with substance use disorders: findings from the MECA Study.

Authors:  D B Kandel; J G Johnson; H R Bird; M M Weissman; S H Goodman; B B Lahey; D A Regier; M E Schwab-Stone
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-06       Impact factor: 8.829

4.  Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey.

Authors:  L A Warner; R C Kessler; M Hughes; J C Anthony; C B Nelson
Journal:  Arch Gen Psychiatry       Date:  1995-03

5.  Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway theory.

Authors:  D B Kandel; K Yamaguchi; K Chen
Journal:  J Stud Alcohol       Date:  1992-09

6.  Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI).

Authors:  H U Wittchen; G Lachner; U Wunderlich; H Pfister
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1998-11       Impact factor: 4.328

7.  Smoking and nicotine dependence. Results from a sample of 14- to 24-year-olds in Germany.

Authors:  C B Nelson; H U Wittchen
Journal:  Eur Addict Res       Date:  1998-03       Impact factor: 3.015

8.  Prevalence of use, abuse and dependence of illicit drugs among adolescents and young adults in a community sample.

Authors:  A Perkonigg; R Lieb; H U Wittchen
Journal:  Eur Addict Res       Date:  1998-03       Impact factor: 3.015

9.  DSM-IV alcohol disorders in a general population sample of adolescents and young adults.

Authors:  C B Nelson; H U Wittchen
Journal:  Addiction       Date:  1998-07       Impact factor: 6.526

Review 10.  Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review.

Authors:  H U Wittchen
Journal:  J Psychiatr Res       Date:  1994 Jan-Feb       Impact factor: 4.791

View more
  7 in total

1.  Psychosocial and Clinical Correlates of Substance use Disorder in an Adolescent Inpatient Psychiatric Population.

Authors:  Marianne Daudin; David Cohen; Yves Edel; Nicolas Bonnet; Nicolas Bodeau; Angèle Consoli; Emmanuelle Deniau; Jean-Marc Guilé
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2010-11

2.  Brief intervention in substance-use among adolescent psychiatric patients: a randomized controlled trial.

Authors:  Javier Goti; Rosa Diaz; Lourdes Serrano; Laura Gonzalez; Rosa Calvo; Antoni Gual; Josefina Castro
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-09-25       Impact factor: 4.785

3.  Patterns of substance use in adolescents attending a mental health department.

Authors:  Rosa Díaz; Javier Goti; Montse García; Antoni Gual; Lourdes Serrano; Laura González; Rosa Calvo; Josefina Castro-Fornieles
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04-21       Impact factor: 4.785

4.  Altered developmental trajectories for impulsivity and sensation seeking among adolescent substance users.

Authors:  Nora E Charles; Stacy R Ryan; Bethany C Bray; Charles W Mathias; Ashley Acheson; Donald M Dougherty
Journal:  Addict Behav       Date:  2016-04-22       Impact factor: 3.913

Review 5.  The clinical and behavioral cardiometabolic risk of children and young people on mental health inpatient units: A systematic review and meta-analysis.

Authors:  Rebekah Carney; Joseph Firth; Rebecca Pedley; Heather Law; Sophie Parker; Karina Lovell
Journal:  Gen Hosp Psychiatry       Date:  2021-03-15       Impact factor: 3.238

6.  Ecological Momentary Assessment and Smartphone Application Intervention in Adolescents with Substance Use and Comorbid Severe Psychiatric Disorders: Study Protocol.

Authors:  Xavier Benarous; Yves Edel; Angèle Consoli; Julie Brunelle; Jean-François Etter; David Cohen; Yasser Khazaal
Journal:  Front Psychiatry       Date:  2016-09-20       Impact factor: 4.157

7.  Substance use and misuse among children and youth with mental illness : A pilot study.

Authors:  V Herz; N Franzin; J Huemer; D Mairhofer; J Philipp; K Skala
Journal:  Neuropsychiatr       Date:  2017-06-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.